• SENSEX 74,529.08
    -329.91 (--0.44%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Pine Labs
    205.00 283.70(%)
  • HDFC Bank
    738.70 682.00(%)
  • Meesho
    244.80 254.65(%)
  • Glass Wall Syst.
    318.00 318.00(%)
  • Cholaman.Inv.&Fn
    1,756.50 1,299.80(%)
  • Solar Industries
    20,243.65 22,630.05(%)
  • Cupid
    265.35 298.95(%)
  • Aster DM Quality
    746.55 519.80(%)
  • Protean eGov
    656.45 940.00(%)
  • Gabriel India
    1,495.35 1,600.00(%)
  • Nippon ETF Liq.
    999.99 978.01(%)
  • Transrail Light
    487.90 800.35(%)
  • Reliance Industries
    1,237.80 1,232.35(%)
  • JSW Dulux
    3,131.20 2,649.05(%)
  • Kaynes Tech
    3,427.35 2,995.85(%)
  • Apar Inds.
    17,916.55 6,800.00(%)
  • Titan Company
    4,983.70 5,187.45(%)
  • Dixon Technolog.
    12,997.00 9,605.05(%)
  • Eternal
    341.80 368.40(%)
  • Larsen & Toubro
    3,867.50 3,288.65(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Beta Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 71606.0
  • ISIN : INE351Y01019
2,105.00 30 (1.47%)
  • As on 23 Sep 2026 (EOD)

  • Today’s Low

    2,063.40

  • Today’s High

    2,170.00

  • Open

    2,080.00

  • Perv Close

    2,074.60

  • 52W Low

    990.10

  • 52W High

    2,807.90

Key Indicators

  • P/E(TTM)

    145.57

  • Mar.Cap (₹Cr.)

    2,333.58

  • Div & Yield %

    0.00

  • Book Value(₹)

    135.76

  • Debt-Equity Ratio

    1.47

  • AGM Date

    22-Sep-2026

  • EPS

    14.46

  • P/E Ratio

    145.57

Financials Ratios

  • Debt-Equity Ratio

    0.13

  • Mar.Cap (₹Cr.)

    2,333.58

  • RONW (%)

    26.03

  • ROCE (%)

    31.56

Score Board

  • Equity (₹ in Cr.)

    11.09

  • BV (₹)

    135.80

  • Sales( ₹ in Cr.)

    225.43

  • NP (in Cr.)

    14.33

  • NP Var(%)

    -24.0

  • Div%

    0.0

  • CPS (₹)

    21.70

  • EPS (₹)

    12.90

  • Traded Value (₹ in Lakhs)

    2,333.58

  • 52 Week High

    2,807.90

  • 52 Week Low

    990.10

  • Price BSE

    0.0

  • Price NSE

    2,105.00

  • Market Capital( in Cr.)

    2,333.58

  • P/C Ratio

    97.20

  • P/E Ratio

    162.80

  • Price Vs.BV

    12.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 220.20 197.62 157.87 124.85 79.46 65.32
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 220.20 197.62 157.87 124.85 79.46 65.32
Other Income 6.19 1.73 1.04 0.86 0.61 0.42
Stock Adjustments 3.70 6.97 3.17 -0.86 1.38 -0.20
Total Income 230.09 206.32 162.08 124.85 81.45 65.54
EXPENDITURE :            
Raw Materials 123.50 119.27 86.47 69.86 44.83 34.61
Power and Fuel Cost 4.22 3.83 3.06 2.28 1.84 1.46
Employee Cost 15.00 11.08 10.31 6.70 4.53 3.70
Other Manufacturing Expenses 18.02 13.61 12.51 10.04 7.65 6.64
Selling and Administration Expenses 31.10 22.77 17.08 9.61 6.23 6.59
Miscellaneous Expenses 5.22 0.50 0.42 0.31 0.45 0.37
Employee Benefit Expenses 15.00 11.08 10.31 6.70 4.53 3.70
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 197.05 171.07 129.85 98.80 65.53 53.36
Operating Profit 33.04 35.26 32.24 26.04 15.92 12.17
Interest 4.76 1.05 0.84 0.41 0.77 0.64
Gross Profit 28.28 34.21 31.40 25.63 15.15 11.53
Depreciation 7.44 4.72 6.19 5.47 5.27 2.58
Profit Before Tax 20.84 29.49 25.21 20.16 9.88 8.95
Current Tax 5.70 7.47 6.68 6.15 3.30 1.72
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.29 0.08 -0.29 -0.24 -0.40 0.13
Reported Net Profit 15.43 21.94 18.82 14.25 6.98 7.10
Extraordinary Items -3.32 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 18.75 21.94 18.82 14.25 6.98 7.10
Adjustment below Net Profit -2.42 -2.18 -0.02 -0.20 0.00 0.00
P & L Balance brought forward 82.46 62.70 43.91 29.86 22.89 15.79
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 95.47 82.46 62.70 43.91 29.86 22.89
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 15.29 22.82 19.57 14.82 7.26 7.39
Earnings Per Share(Adj)-Unit Curr 15.29 22.82 18.64 14.82 6.91 7.04
Book Value 127.83 120.67 100.12 80.57 65.96 58.71
Book Value(Adj)-Unit Curr 127.83 120.67 95.35 80.57 62.82 55.92

Shareholding Pattern

  • Promoter Group

    59.10%

  • Public Share Holding

    40.90%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 6,551,392 59.10 6,551,392 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6,551,392 59.10 6,551,392 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 113,166 1.02 113,166 6
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 691,196 6.24 691,196 8
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 804,362 7.26 804,362 14
2] Non Institution
Bodies Corporate 868,650 7.84 868,650 66
Clearing Members 2,444 0.02 2,444 9
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 104,707 0.94 104,707 255
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 48,712 0.44 48,712 146
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,270,367 11.46 1,270,367 11
Individuals holding nominal share capital up to Rs. 1 lakh 1,423,650 12.84 1,423,650 6,839
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,730,118 33.65 3,730,118 7,340
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,085,872 100.00 11,085,872 7,359

Company Background

Beta Drugs LtdPharmaceuticals - Indian - Bulk Drugs

  • Beta Drugs Ltd
  • BSE Code : 71606.0
  • ISIN : INE351Y01019

  • Incorporation Year

    2005

  • Registered Office

    Village Nandpur
    , Baddi,
    Himachal Pradesh-174101

  • Telephone

    91-1795-236196

  • FAX

  • Chairman

    Rahul Batra

  • Managing Director

    Rahul Batra

  • Company Secretary

    Rajni Brar

  • Auditor

    Khurana Sharma & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Beta Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Beta Drugs Ltd 2,105.00 226.39 220.20 145.57 15.57
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77